Home > Boards > US Listed > Biotechs > Proqr Therapeutics B.V. (PRQR)

I predict we come back down from here

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
s366sxe Member Profile
 
Followed By 4
Posts 346
Boards Moderated 0
Alias Born 11/04/17
160x600 placeholder
ProQR Therapeutics Shares Rise 29% After Research Deal With Lilly Dow Jones News - 9/9/2021 11:20:00 AM
ProQR Therapeutics, Centessa Pharmaceuticals leads healthcare gainers; Humanigen, Invacare among major losers Seeking Alpha - 9/9/2021 10:59:06 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/9/2021 8:02:33 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/8/2021 4:11:23 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/5/2021 8:32:05 AM
ProQR reports Q2 results Seeking Alpha - 8/5/2021 7:58:38 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 7/8/2021 4:41:52 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/20/2021 4:32:28 PM
ProQR reports Q1 results Seeking Alpha - 5/6/2021 7:31:01 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/6/2021 7:16:59 AM
ProQR shares rise after inking Yarrow Biotechnology deal Seeking Alpha - 5/4/2021 8:31:14 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/4/2021 7:27:33 AM
ProQR Therapeutics offers a de-risked opportunity: Stifel Seeking Alpha - 5/3/2021 1:10:16 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/20/2021 7:48:24 AM
ProQR's sepofarsen shows promise in blindness study Seeking Alpha - 4/13/2021 4:34:17 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/6/2021 4:06:47 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 4/6/2021 6:01:36 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/1/2021 5:24:58 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/1/2021 5:23:17 PM
ProQR raises $90M capital via share offering Seeking Alpha - 3/30/2021 11:58:02 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/30/2021 5:43:22 PM
ProQR proposes capital raise Seeking Alpha - 3/30/2021 4:08:59 PM
Analyst Lights Up Over ProQR Blindness Trial Results TipRanks - 3/26/2021 12:33:18 PM
ProQR Therapeutics up 36% following price target increase at Citi Seeking Alpha - 3/25/2021 11:19:24 AM
ProQR Therapeutics’ RNA therapy for Usher syndrome to reach pivotal trials Seeking Alpha - 3/24/2021 11:54:09 AM
s366sxe   Wednesday, 09/05/18 07:32:47 PM
Re: murocman post# 22
Post # of 120 
I predict we come back down from here

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences